Owen A. O’Connor, M.D., Ph.D is a Physician-scientist, Cancer Researcher, and Medical Oncologist. O’Connor is Professor of Medicine and Pharmacology, Deputy Director for Clinical Research and Cancer Treatment and Director, at the Division of Hematology and Medical Oncology at New York University’s Cancer Institute - NYU Langone Medical Center. NYU Langone Medical Center is an academic medical center located on the eastside of Manhattan in New York City. and ranked among the top 20 hospitals in the United States. Prior to his roles at NYU Langone Medical Center, O’Connor worked at Memorial Sloan Kettering Cancer Center and Columbia University Medical Center. O’Connor is a graduate of Manhattan College, NYU, and Robert Wood Johnson Medical School, New Brunswick, N.J. Over the past decade, O’Connor’s work has contributed to the FDA approval of three distinct drugs. O’Connor’s laboratory is now focused on the discovery and development of promising new small molecules that target the all-important NF-κB signaling pathway in cancer cells. In partnership with colleagues from Columbia University, O’Connor is a co-founder of a small biotechnology company, THERASIS, which is focused on using high-throughput chemical screening approaches and systems biology applications to accelerate the discovery of promising new anti-cancer drugs. O’Connor is the recipient of several honors and awards. All four of O’Connor’s grandparents were born in Ireland – Mayo, Galway, Cork and Kerry. O’Connor is married to Rosella and they have two children. They reside Scarsdale, NY.
Return to Life Science 50